Koya Keizo
Sr. VP, Drug Development at MDGL
- Sold, on record
- $244k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Mar 1, 2012
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- MDGLMADRIGAL PHARMACEUTICALS, INC.Sr. VP, Drug Development
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale MDGLUnusualMar 1, 2011 2011
Sold 18,270 shares at $5.23 ($96k)
Koya Keizo, Sr. VP, Drug Development
Sold 35.6% of holdings ($268k position)32,999 shares leftFirst sale on recordFiling
- 2 Form 4 sale MDGLUnusualApr 25, 2011 +55 days
Sold 20,000 shares at $5.80 ($116k)
Koya Keizo, Sr. VP, Drug Development
Sold 50.2% of holdings ($231k position)19,843 shares leftFiling
- 3 Form 4 sale MDGLUnusualMar 1, 2012 +311 days
Sold 6,844 shares at $4.70 ($32k)
Koya Keizo, Sr. VP, Drug Development
Sold 34.5% of holdings ($93k position)12,999 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2012 | Mar 5, 2012 | MDGL | Sr. VP, Drug Development | Form 4 sale | 6,844 | $32k | 34.5% | Unusual | SEC |
| Apr 25, 2011 | Apr 26, 2011 | MDGL | Sr. VP, Drug Development | Form 4 sale | 20,000 | $116k | 50.2% | Unusual | SEC |
| Mar 1, 2011 | Mar 3, 2011 | MDGL | Sr. VP, Drug Development | Form 4 sale | 18,270 | $96k | 35.6% | Unusual | SEC |